Biomerica
BMRA
About: Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Employees: 54
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
2.08% more ownership
Funds ownership: 0.65% [Q1] → 2.73% (+2.08%) [Q2]
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
54% less funds holding
Funds holding: 24 [Q1] → 11 (-13) [Q2]
60% less capital invested
Capital invested by funds: $543K [Q1] → $220K (-$323K) [Q2]
96% less call options, than puts
Call options by funds: $14K | Put options by funds: $315K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 13
Financial journalist opinion
Based on 3 articles about BMRA published over the past 30 days
